Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation

Is transesophageal echocardiogram mandatory in patients undergoing ablation of atrial fibrillation with uninterrupted novel oral anticoagulants? Results from a prospective multicenter registry

(2016) Luigi Di Biase et al.   HEART RHYTHM

Comparison of Safety of Left Atrial Catheter Ablation Procedures for Atrial Arrhythmias Under Continuous Anticoagulation With Apixaban Versus Phenprocoumon

(2015) Bernhard M. Kaess et al.   AMERICAN JOURNAL OF CARDIOLOGY

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

(2015) Riccardo Cappato et al.   EUROPEAN HEART JOURNAL

Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study

(2015) Luigi Di Biase et al.   HEART RHYTHM

Feasibility and Safety of Uninterrupted Dabigatran Therapy in Patients Undergoing Ablation for Atrial Fibrillation

(2015) Tomoyuki Nagao et al.   INTERNAL MEDICINE

Perioperative anticoagulation—are we at 'a bridge too far'?

(2015) James D. Douketis   Nature Reviews Cardiology

Apixaban is Dear to Me, but Dearer Still is Warfarin

(2015) LUIGI DI BIASE et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Heparin Kinetics: The “Holy Grail” of Periprocedural Anticoagulation for Ablation of Atrial Fibrillation

(2015) DAVID F. BRICENO et al.   PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY

Meta-Analysis of Efficacy and Safety of Rivaroxaban Compared With Warfarin or Dabigatran in Patients Undergoing Catheter Ablation for Atrial Fibrillation

(2014) Madan Raj Aryal et al.   AMERICAN JOURNAL OF CARDIOLOGY

Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management

(2014) Luigi Di Biase et al.   CIRCULATION

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   CIRCULATION

Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study

(2014) Luigi Di Biase et al.   HEART RHYTHM

Safety and efficacy of novel oral anticoagulants in the setting of atrial fibrillation ablation: Is it time to celebrate the “funeral” of warfarin?

(2014) Luigi Di Biase   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation

(2014) Dhanunjaya Lakkireddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation

(2013) Mohamed Bassiouny et al.   Circulation-Arrhythmia and Electrophysiology

Neuropsychological Effects of MRI-Detected Brain Lesions After Left Atrial Catheter Ablation for Atrial Fibrillation

(2013) Juliane Herm et al.   Circulation-Arrhythmia and Electrophysiology

Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature

(2013) Stefan H. Hohnloser et al.   EUROPACE

Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology/European Heart Rhythm Association/European Association of Cardiothoracic Surgeons, the American College of Cardiology Foundation/American Heart Association/Heart Rhythm Society, and the Canadian Cardiovascular Society

(2013) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies

(2013) Benjamin A. Steinberg et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Outcomes of Medicare Beneficiaries Undergoing Catheter Ablation for Atrial Fibrillation

(2012) Jonathan P. Piccini et al.   CIRCULATION

Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

(2012) Gjin Ndrepepa et al.   CIRCULATION

Efficacy and Safety of Periprocedural Dabigatran in Patients Undergoing Catheter Ablation of Atrial Fibrillation

(2012) Kenichi Kaseno et al.   CIRCULATION JOURNAL

A comparison of bleeding complications post-ablation between warfarin and dabigatran

(2012) David Snipelisky et al.   JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

(2012) Paulus Kirchhof et al.   LANCET

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

(2011) Roxana Mehran et al.   CIRCULATION

Catheter ablation of atrial fibrillation

(2011) Pasquale Santangeli et al.   Journal of Cardiovascular Medicine

Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation

(2010) Luigi Di Biase et al.   CIRCULATION

Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries

(2009) Ethan R. Ellis et al.   HEART RHYTHM